Literature DB >> 16488374

GDNF in treatment of Parkinson's disease: response to editorial.

Richard D Penn, Arif Dalvi, John Slevin, Byron Young, Don Gash, Greg Gerhardt, Michael Hutchinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16488374     DOI： 10.1016/S1474-4422(06)70360-X

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  6 in total

Review 1.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

Review 2.  Ethical issues in clinical neuroscience research: a patient's perspective.

Authors:  Perry D Cohen; Linda Herman; Sheryl Jedlinski; Peggy Willocks; Paula Wittekind
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 3.  Physical Exercise and Health: A Focus on Its Protective Role in Neurodegenerative Diseases.

Authors:  Roberto Bonanni; Ida Cariati; Umberto Tarantino; Giovanna D'Arcangelo; Virginia Tancredi
Journal:  J Funct Morphol Kinesiol       Date:  2022-04-29

4.  Evaluation of an AAV2-based rapamycin-regulated glial cell line-derived neurotrophic factor (GDNF) expression vector system.

Authors:  Piotr Hadaczek; Janine Beyer; Adrian Kells; Wade Narrow; William Bowers; Howard J Federoff; John Forsayeth; Krystof S Bankiewicz
Journal:  PLoS One       Date:  2011-11-21       Impact factor: 3.240

5.  Failure of Glial Cell-Line Derived Neurotrophic Factor (GDNF) in Clinical Trials Orchestrated By Reduced NR4A2 (NURR1) Transcription Factor in Parkinson's Disease. A Systematic Review.

Authors:  Piniel Alphayo Kambey; Kouminin Kanwore; Abiola Abdulrahman Ayanlaja; Iqra Nadeem; YinZhen Du; Wokuheleza Buberwa; WenYa Liu; Dianshuai Gao
Journal:  Front Aging Neurosci       Date:  2021-02-24       Impact factor: 5.750

6.  Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications.

Authors:  Massimo S Fiandaca; Krystof S Bankiewicz; Howard J Federoff
Journal:  Pharmaceuticals (Basel)       Date:  2012-06-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.